180 related articles for article (PubMed ID: 8099290)
1. Continuous versus intermittent neuroleptic therapy in schizophrenia.
Jolley AG; Hirsch SR
Drug Saf; 1993 May; 8(5):331-9. PubMed ID: 8099290
[No Abstract] [Full Text] [Related]
2. Strategies for enhancing drug therapy of schizophrenia.
Schooler NR; Levine J
Am J Psychother; 1983 Oct; 37(4):521-32. PubMed ID: 6140869
[TBL] [Abstract][Full Text] [Related]
3. Ideal and reality of neuroleptic relapse prevention.
Kissling W
Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363
[No Abstract] [Full Text] [Related]
4. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
Kristjansen P
Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
[No Abstract] [Full Text] [Related]
5. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
Johnson DA
J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of schizophrenia].
Bitter I
Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
[No Abstract] [Full Text] [Related]
7. Decreased urinary peptide excretion in schizophrenic patients after neuroleptic treatment.
Reichelt KL; Teigland-Gjerstad B
Psychiatry Res; 1995 Sep; 58(2):171-6. PubMed ID: 8570770
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic depression in schizophrenia.
Harrow M; Fichtner CG; Grossman LS; Yonan CA; Sands J
Biol Psychiatry; 1991 Oct; 30(8):845-8. PubMed ID: 1684298
[No Abstract] [Full Text] [Related]
9. Alprazolam-neuroleptic combination in schizophrenia.
Lipinski JF; Cohen BM
Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
[No Abstract] [Full Text] [Related]
10. [Education groups in neuroleptic treatment of schizophrenic patients].
Gaillard P; Degiovanni A; Parrot F
Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
[No Abstract] [Full Text] [Related]
11. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
Meltzer HY
Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
[No Abstract] [Full Text] [Related]
12. First-episode schizophrenia.
Robinson D
CNS Spectr; 2010 Apr; 15(4 Suppl 6):4-7. PubMed ID: 21141653
[No Abstract] [Full Text] [Related]
13. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
14. Early, targeted pharmacotherapeutic intervention in schizophrenia.
Carpenter W
J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
[TBL] [Abstract][Full Text] [Related]
15. Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients.
McClelland HA; Harrison G; Soni SD
Br J Psychiatry; 1989 Nov; 155():702-6. PubMed ID: 2575424
[No Abstract] [Full Text] [Related]
16. [The "neuroleptic threshold"--a review of the literature].
Abraham D; Kissling W; Lauter H
Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
18. Transient recurrence of auditory hallucinations during acute dystonia.
Chiu LP
Br J Psychiatry; 1989 Jul; 155():110-3. PubMed ID: 2575002
[TBL] [Abstract][Full Text] [Related]
19. Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients.
Xiu MH; Chen S; Wang F; Cao LY; Qi LY; Chen DC; Wu GY; Lu L; Kosten TA; Kosten TR; Zhang XY
Schizophr Res; 2008 Dec; 106(2-3):369-70. PubMed ID: 18838250
[No Abstract] [Full Text] [Related]
20. [Lifelong relapse prevention with antipsychotics in schizophrenia].
Hasan A; Wobrock T
Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
